Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain finalist of the South Summit Madrid

News
gate2brain finalist south summit 2023south summit

Gate2Brain has been named a finalist in the Health Category of the South Summit Madrid 2023.

The event will take place on June 7th-9th, where Gate2Brain will join a community of forward-thinking individuals, entrepreneurs, and investors to shape the future.

The event promises to be three days of inspiring talks, workshops, and networking opportunities!!

If you’re interested in learning more about Gate2Brain’s technology for delivering therapeutics across biological barriers, you can attend our pitch given by Helena Castillo Ecija PhD, MBA, Gate2Brain’s R&D Preclinical Project Manager, or schedule a One-on-One Meeting .

May 4, 2023/by noticias
Tags: SouthSummit2023
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/05/South-summit-finalist.png 1080 1920 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-05-04 13:25:042023-05-04 13:25:04Gate2Brain finalist of the South Summit Madrid

CATEGORIES

  • Clipping
  • Events
  • Media
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • StartUBUniversitat de BarcelonaStartUB dayMay 24, 2023 - 08:57
  • Tides 2023G2BTides USA 2023 Oligonucleotide & Peptide TherapeuticMay 16, 2023 - 16:50
  • Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production ModelsApril 21, 2023 - 09:10
  • https://www.lsxleaders.com/lsx-world-congressG2BG2B at LSX World Congress 2023April 18, 2023 - 07:30
  • CataloniaBio & Health Teach GalaG2BCataloniaBio HT Gala 2023March 29, 2023 - 12:00

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • HIGHLIGHTS: New CAR-T, investment rounds, capital movements and advances in oncology and Alzheimer May 25, 2023 biocat
  • The 4th edition of the e-Health Investment Forum dedicated to clinical decision making May 25, 2023 biocat
  • Open call for the 6th edition of the CRAASH Barcelona program May 24, 2023 biocat
  • Montserrat Daban, new President of Council of European BioRegions (CEBR) May 24, 2023 biocat
  • Successful 2nd edition of the “Fast-track to Barcelona-Catalonia Life Science Hub” program focused on advanced therapies May 24, 2023 biocat
  • The new investment platform in the BioRegion May 5, 2023 biocat
  • Funding breakfast, lead-up to BIOSPAIN Barcelona April 27, 2023 biocat
  • 45 companies and organisations from the BioRegion to participate in BIO Boston 2023 convention April 26, 2023 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Three University of Barcelona spin-offs will receive funding from Women TechEU...Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaTides 2023G2BTides USA 2023 Oligonucleotide & Peptide Therapeutic
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}